ThermoGenesis Holdings, Inc.

THMO Healthcare Medical Devices

ThermoGenesis Holdings, Inc.’s revenue for fiscal 2023 (year ended December 2023) was $9.4 million, down 9.90% from fiscal 2022. Operating cash flow growth for three consecutive years.

0.00 0.00 NaN
Market cap
$1.1M
P/E
0.0×
Fwd P/E
5.5×
Dividend yield
—
F-score
3/9
Altman Z
−37.75
Beneish M
−9.50
Dividend safety
n/a
Mar '24 Dec '23 Sep '23 Jun '23 Older periods
Piotroski F-Score
3 3 3 2

+8 more TTM periods

ROE
(751.34%) 13,773.95% (382.33%) (344.59%)
ROA
(98.83%) (117.41%) (79.93%) (72.01%)
ROIC
0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
996.96% 449.82% (2,579.39%) 14,018.00%
Average Days of Receivables
43.64 36.67 13.83 29.32
Free Cash Flow per Share
(1.14) (2.30) (1.79) (2.08)
Free Cash Flow
(4.59) (5.45) (4.49) (5.15)
Other line items

Show all line items

Columns are period end dates